Need help finding something?

Office Location & Hours

903 William D. Fitch Pkwy
College Station, TX 77845
Phone Number: (979) 779-9000
Fax Number: (979) 690-1510

Get Directions

Mon, Thurs:
Wednesday:
Tue, Fri.:

8am - 7pm
9am - 5:30pm
8am - 5:30pm

Patient Testimonials

  • Matthew G.

    Absolutely amazing facility! They helped my son and even helped watch him for a minute when my bank gave me trouble. They were very kind and understanding....

  • Rebecca K.

    I went in for vitamins and information. The young lady at recept. Desk did an awesome job with my qqq and handled the vitamin sale with more information needed for my eye condition....

  • Bernadette H.

    Had to find a new eye doctor for my family and I due to insurance changes. I was very pleased with my first experience. Staff and Dr. Dobson are very friendly and professional. Felt comfortable and welcomed to the practice. Would recommend giving...

  • Alexander M.

    I am new to the bryan college station area being a college student. I needed to find a new eye doctor. I am one of those people that, take a long time exsploring my options online. When I first started my search they were the first ones that poped onto my screen. When I looked at there website I intantly felt like this was the one...

    Corneal Crosslinking offers a solution for slowing or halting the progression of keratoconus. For patients who have keratoconus, crosslinking provides an attractive and minimally invasive tactical approach to slow the disease. At Eye Care Center, Dr. Belinda Dobson examines the cornea and determines if one is a candidate for crosslinking. If we determine corneal collagen crosslinking is an option for the management of keratoconus, we perform the pre-operative examination and carefully work with Dr. Slade’s office to orchestrate the treatment phase.

    Purpose:

    Corneal Crosslinking (CXL) is an investigational treatment for Keratoconus patients and Post Lasik Ectasia patients that experience corneal thinning after Refractive Surgery. This trial is studying if this one-time treatment will strengthen the cornea so that the progression of Keratoconus and Corneal Ectasia is slowed or stopped.

    Background:

    Corneal Collagen Crosslinking (CXL) has been proven in studies outside of the US to strengthen a weakened corneal structure, as in keratoconus. CXL is currently in US Food and Drug Administration (FDA) clinical trials to seek FDA approval.

    Keratoconus/Effects:

    The cornea is the clear membrane that covers the colored part of the eye and pupil. The cornea is the “window” of the eye and is the most powerful lens in the eye as well. Keratoconus is a corneal disease that causes structural changes within the cornea causing the cornea to thin and bulge outward into a steeper, irregular, more conical shape than its normal gradual curve. Keratoconus can cause substantial visual loss of vision, image distortion, streaking of lights, sensitivity to light, and multiple images, etc.

    Keratoconus affects about one person in a thousand, and yet the exact cause of it is uncertain. It has been associated with genetic factors and linked to detrimental abnormal enzyme activity in the cornea; however, the findings are still inconclusive. Many patients with keratoconus may be treated with corrective lenses, glasses, contact lenses, intrastromal corneal ring segments, and as a last resort, corneal transplantation. In order to stabilize the cornea, keep the keratoconus from progressing and even avoid having to have a corneal transplant, many patients now have chosen to travel around the world to have corneal collagen crosslinking, also known as "CXL."

    Goal:

    Crosslinking (CXL) has been shown to increase the number of corneal crosslinks within the cornea. These links are like the natural anchors in the cornea and are responsible for preventing the cornea from bulging outwards and becoming steep and irregular. The goals of crosslinking are to stop the progression of keratoconus, decrease the severity of the corneal bulging, and allow the patient to continue or resume contact lens wear. By decreasing the severity of the corneal bulging, doctors are better able to fit the patient for contact lenses.

    Study Parameters:

    You may be eligible for this study if you are 12 years of age or older and have been diagnosed with Keratoconus or diagnosed with Corneal Ectasia after refractive surgery (e.g. LASIK, PRK). There are specific inclusion and exclusion criteria that patients must meet in order to be considered participants in the clinical trial. We will be happy to discuss these with you.

    Procedure:

    The crosslinking treatment is an outpatient procedure performed in the surgical laser suite using numbing eye drops. During this study, the surgeon uses an ultraviolet-A illumination device (UVA light treatment), called the KXL system in combination with VibeX (vitamin B2) eye drops to treat the cornea (front of the eye). First, in the Epithelial Off procedure, the outer layer of the cornea, the epithelium, is prepared for the procedure. If a patient is having the Epithelial On procedure, this step is skipped. Next, vitamin B2 (riboflavin) eye drops are instilled in the eye and the patient is asked to look at an ultraviolet light while lying comfortably in a reclining chair. The entire procedure generally takes only a few minutes. The patient’s eyes are numbed through the use of anesthetic drops.

    After treatment:

    Post operatively, most patients start to notice the effects in their vision 4-8 weeks after the traditional (epithelial-off) procedure and the final effects usually take 3-6 months. Every patient is different, visual results may differ.

    If you are interested in learning more about CXL or keratoconus, please call us at (979) 779-9000 and ask for Madeline.

    Please visit the National Keratoconus Foundation's website to see all the approved CXL sites in the United States.

    Exceptional Staff

    Exceptional Staff

    You'll be hard-pressed to find a more experienced, caring vision care team in all of Texas!

    Our History

    Our History

    Since its inception in 1983 by Dr. Sue Simpson, O.D., Eye Care Center has always been committed to quality eye wear, top-notch eye exams, and exceptional patient satisfaction.

    Common Patient Questions

    Common Patient Questions

    Odds are that someone else has asked us the very same question you're wondering about. If not, feel free to reach out to us!

    What Sets us Apart

    What Sets us Apart

    From the moment you arrive for your visit, YOU are our number one priority. Our belief is that if we truly get to know our patients and what makes them happy, we can visually accommodate them in every stage of life.

    Featured Video

    Please take a moment to browse our high definition educational animations and videos to learn about vision health. Please contact us with any questions.

    bcm_videoplayer_banner

    Office Location & Hours

    903 William D. Fitch Pkwy
    College Station, TX 77845
    Phone Number: (979) 779-9000
    Fax Number: (979) 690-1510

    Get Directions

    Mon, Thurs:
    Wednesday:
    Tue, Fri.:

    8am - 7pm
    9am - 5:30pm
    8am - 5:30pm

    Accepted Payment Methods

    payment cashpayment checkpayment care creditpayment visaMastercardDiscoverAmerican Express